Long-term nephroprotective effects of sparsentan in FSGS Presented ByDr Tarak Srivastava, Children’s Mercy Hospital, USA TrialPhase 2, DUET ConferenceASN 2022 TypePeer-reviewed article 8 December 2022 14:55